Research & Development

色姐妹综合网亚州性夜夜射色大姐综合网 色天使在线中国证券业协会安青松:加快完善资本市场基础制度


  “婢子剛才差點睡著了,您跟別人的談話,婢子沒有听見。”   不過,他沒錢!色姐妹综合网   平叟接過卓姬遞過來的竹簡,打開看了一遍,不由得低聲吟誦道。亚州性夜夜射   “齊王死定了是吧?”雲瑯滿懷期望的問道。   司馬遷笑著把自己的那一份推給任安道︰“那就多吃一些,不過啊,到了午時吃飯的時候,別後悔就是了。”色大姐综合网 色天使在线   雲瑯吧嗒一下嘴巴,瞅著張湯道︰“沒的更換?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo